GRANT HUGH 4

What Happened

• Hugh Grant, a member of the Linde plc Board of Directors, was granted derivative equity on 2026-03-09: 473 restricted stock units (RSUs) and 79.233 additional deferred RSUs. Both line items show an acquisition at $0.00 (award).
• These are awards/derivative securities (transaction code A), not open-market purchases or sales. No cash was paid; the awards convert 1-for-1 into Linde ordinary shares per the filing.

Key Details

• Transaction date: March 9, 2026; Form 4 filed March 10, 2026 (timely).
• Grants listed: 473 RSUs @ $0.00 and 79.233 RSUs @ $0.00 (total 552.233 RSUs). Reported value shown as $0 because these are awards/derivative units.
• Shares owned after the transaction: not specified in the filing.
• Relevant footnotes summarized:
  • F1: Conversion to Linde ordinary shares is on a 1-for-1 basis.
  • F2: The 473-RSU award vests in full one year after the March 9, 2026 grant if the director remains on the Board; payout of vested RSUs has been deferred until the reporting person’s termination of service.
  • F3: Some RSUs noted are fully vested but the reporting person has deferred payout until termination of service.
  • F4: Certain units are deferred stock units under the Non‑Employee Director Deferral Plan and will pay out 1-for-1 in ordinary shares per the plan.
• Filing appears routine compensation for a director (no 10b5‑1 plan, tax withholding, or late‑filing flags noted).

Context

• These RSUs are compensation/deferral instruments (no immediate sale or cash exercise). They do not reflect an open‑market buy or sell and are common for non‑employee director pay.
• Vesting and deferred payout terms mean shares may not be issued until vesting or the director’s termination of service, so there is no immediate change in market exposure for the director.